Drugs for the treatment of psoriatic arthritis can be divided into several categories: nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs) and biologics, which are also considered DMARDs. A number of alternative and complementary approaches are also used in the treatment of psoriatic arthritis. Â
The following treatments are not listed in any order of importance. Each case must be evaluated individually.
Aspirin and NSAIDs
Nonsteroidal anti-inflammatory drugs (NSAIDs), including over-the-counter medications such as aspirin and ibuprofen as well as prescription products, help to decrease inflammation, joint pain and stiffness.
DMARDs and biologics
Disease-modifying antirheumatic drugs (DMARDs) may relieve more severe symptoms and attempt to slow or stop joint and tissue damage and progression of psoriatic arthritis.
Biologics, such as Enbrel, Humira and Remicade, are also considered DMARDs. They are highly selective agents that target specific internal events in the body that cause psoriasis and psoriatic arthritis.
![]() |
Argentina |
![]() |
Australia |
![]() |
Belgium |
![]() |
Canada |
![]() |
China |
![]() |
Denmark |
![]() |
Estonia |
![]() |
Finland |
![]() |
France |
![]() |
Germany |
![]() |
Iceland |
![]() |
Indonesia |
![]() |
Japan |
![]() |
Kenya |
![]() |
Malta |
![]() |
Netherlands |
![]() |
New Zealand |
![]() |
Norway |
![]() |
Philippines |
![]() |
Singapore |
![]() |
South Africa |
![]() |
Spain |
![]() |
Sweden |
![]() |
Switzerland |
![]() |
Tanzania |
![]() |
United Kingdom |
![]() |
USA |